Mounting evidence for lack of PCI benefit in stable ischemic heart disease: What more will it take to turn the tide of treatment?

Archives of Internal Medicine

Volumn 172, Issue 4, 2012, Pages 319-321

  Boden, William E ^a  

^a ALBANY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPLASTY; CLINICAL EFFECTIVENESS; CORONARY STENT; COST CONTROL; EVIDENCE BASED MEDICINE; HEALTH CARE COST; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; ISCHEMIC HEART DISEASE; MEDICATION THERAPY MANAGEMENT; META ANALYSIS (TOPIC); MORTALITY; NOTE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REIMBURSEMENT; STABLE ANGINA PECTORIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, BALLOON, CORONARY; COMBINED MODALITY THERAPY; CORONARY ARTERY DISEASE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE;

EID: 84857870717     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2011.2321     Document Type: Note

References (10)

1. Boden WE, O'Rourke RA, Teo KK, et al COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356(15):1503-1516. (Pubitemid 46588415)
2. Frye RL, August P, Brooks MM, et al; BARI 2D Study Group. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med. 2009;360(24):2503-2515.
3. Nishigaki K, Yamazaki T, Kitabatake A, et al Japanese Stable Angina Pectoris Study Investigators. Percutaneous coronary intervention plus medical therapy reduces the incidence of acute coronary syndrome more effectively than initial medical therapy only among patients with low-risk coronary artery disease a randomized, comparative, multicenter study. JACC Cardiovasc Interv. 2008;1(5):469-479.
4. Kereiakes DJ, Teirstein PS, Sarembock IJ, et al. The truth and consequences of the COURAGE trial. J Am Coll Cardiol. 2007;50(16):1598-1603. (Pubitemid 47542361)
5. Schömig A, Mehilli J, de Waha A, Seyfarth M, Pache J, Kastrati A. A meta-analysis of 17 randomized trials of a percutaneous coronary intervention-based strategy in patients with stable coronary artery disease. J Am Coll Cardiol. 2008;52(11):894-904.
6. Jeremias A, Kaul S, Rosengart TK, Gruberg L, Brown DL. The impact of revascularization onmortality in patients with nonacute coronary artery disease. Am J Med. 2009;122(2):152-161.
7. Wijeysundera HC, Ko DT. Does percutaneous coronary intervention reduce mortality in patients with stable chronic angina: are we talking about apples and oranges? Circ Cardiovasc Qual Outcomes. 2009;2(2):123-126.
8. Stergiopoulos K, Brown DL. Initial coronary stent implantation with medical therapy vs medical therapy alone for stable coronary artery disease: meta-analysis of randomized controlled trials. Arch Intern Med. 2012;172(2):312-319.
9. Diamond GA, Kaul S. Evidence-based financial incentives for healthcare reform: putting it together. Circ Cardiovasc Qual Outcomes. 2009;2(2):134-140.
10. Borden WB, Redberg RF, Mushlin AI, Dai D, Kaltenbach LA, Spertus JA. Patterns and intensity of medical therapy in patients undergoing percutaneous coronary intervention. JAMA. 2011;305(18):1882-1889.